(Q84958986)

English

The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study

scientific article published on 27 November 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19943156%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19943156%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19943156%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

C. Daniel Mullins

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19943156%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

27 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19943156%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19943156%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

53

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19943156%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19943156%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

489-496

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19943156%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type 2 diabetes, thiazolidinediones: bad to the bone?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of thiazolidinediones and fracture risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fracture risk is a class effect of glitazones

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinedione therapy gets complicated: is bone loss the price of improved insulin resistance?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes drugs tied to fractures in women

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone is a target for the antidiabetic compound rosiglitazone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoporosis and fracture risk in women of different ethnic groups

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinedione use and bone loss in older diabetic adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19943156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84958986&oldid=2221686114"